ResMed, Apex Medical Fight Over Terms Of ITC Sleep Aid Deal

Law360, New York (July 17, 2013, 4:47 PM ET) -- ResMed Corp. on Tuesday told the U.S. International Trade Commission that Apex Medical Corp.’s proposed agreement to end a patent infringement investigation is insufficient, an objection that could hinder negotiations to close a dispute over sleep disorder breathing devices.  

California-based ResMed said in an opposition motion before the ITC that its Taiwanese rival could not meet Commission requirements merely by agreeing not to import products that infringe ResMed’s asserted patents. Instead, ResMed says Apex must submit a stipulation to its consent order that additionally promises...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers